Skip to main content
Premium Trial:

Request an Annual Quote

Money, Money, Money

To keep biomedical research chugging along happily, the Federation of American Societies for Experimental Biology says the NIH budget needs to get raises after the stimulus funding runs out. According to Science Insider, NIH needs a 10 percent raise in 2011 and 3 percent above inflation (6 to 7 percent) raises after that, so that in 2012, the NIH budget would be $36 billion. If these increases do not happen, incoming FASEB president Mark Lively says, new awards will plummet. "We're going to slow progress; we're going to end careers; we're going to be terribly discouraging to young scientists," he says. Lively also suggests that investigators be given more time to spend their stimulus funds.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.